Combined approach with infliximab, surge
✍
Pauline Roumeguère; Dominique Bouchard; François Pigot; Alain Castinel; Frederic
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 310 KB
Background: Infliximab is the only medical therapy that has been proven to be effective in fistulizing Crohn's disease (CD), but the recurrence rate of fistulas is high despite maintenance therapy. The aim of this prospective study was to evaluate the short-and long-term efficacy of a combined sched